Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadine Hartmann

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Environmental Research and Public Health|August 29, 2024
Health, Performance Ratings and Approachability of 50-60-Year-Old Sedentary Adults (ActIv-Study): Key Insights for Health Economy and Exercise PromotionDieter Leyk, Nadine Hartmann, Emanuel Vits, et al.
Advances in Therapy|June 22, 2021
Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database AnalysisAmy L Olson, Padmaja Patnaik, Nadine Hartmann, et al.
Respiration; International Review of Thoracic Diseases|January 27, 2020
Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims DataKathleen M Mortimer, Dorothee B Bartels, Nadine Hartmann, et al.
Molecular Immunology|June 26, 2018
Role of MAIT cells in pulmonary bacterial infectionNadine Hartmann, Melanie J Harriff, Curtis P McMurtrey, et al.
Advances in Therapy|February 24, 2022
Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database AnalysisAmy L Olson, Nadine Hartmann, Padmaja Patnaik, et al.
Journal of Bacteriology|July 1, 2015
Xanthomonas campestris pv. vesicatoria Secretes Proteases and Xylanases via the Xps Type II Secretion System and Outer Membrane VesiclesMagali Solé, Felix Scheibner, Anne-Katrin Hoffmeister, et al.
Advances in Therapy|December 14, 2020
Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician SurveyAmy Olson, Nadine Hartmann, Padmaja Patnaik, et al.
Annals of the American Thoracic Society|June 24, 2020
Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO RegistryMargaret L Salisbury, Craig S Conoscenti, Daniel A Culver, et al.
Clinical Breast Cancer|June 12, 2026
Prevalence and Prognostic Implications of Circulating Tumor Cells Among Patients Undergoing Neoadjuvant Chemotherapy for Early-Stage Breast CancerMark Freeman, Alicja Prawdzic Senkowska, Rania Chehade, et al.
American Journal of Respiratory Cell and Molecular Biology|January 23, 2018
Riboflavin Metabolism Variation among Clinical Isolates of Streptococcus pneumoniae Results in Differential Activation of Mucosal-associated Invariant T CellsNadine Hartmann, Curtis McMurtrey, Michelle L Sorensen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Environmental Research and Public Health|August 29, 2024
Health, Performance Ratings and Approachability of 50-60-Year-Old Sedentary Adults (ActIv-Study): Key Insights for Health Economy and Exercise PromotionDieter Leyk, Nadine Hartmann, Emanuel Vits, et al.
Advances in Therapy|June 22, 2021
Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database AnalysisAmy L Olson, Padmaja Patnaik, Nadine Hartmann, et al.
Respiration; International Review of Thoracic Diseases|January 27, 2020
Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims DataKathleen M Mortimer, Dorothee B Bartels, Nadine Hartmann, et al.
Molecular Immunology|June 26, 2018
Role of MAIT cells in pulmonary bacterial infectionNadine Hartmann, Melanie J Harriff, Curtis P McMurtrey, et al.
Advances in Therapy|February 24, 2022
Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database AnalysisAmy L Olson, Nadine Hartmann, Padmaja Patnaik, et al.
Journal of Bacteriology|July 1, 2015
Xanthomonas campestris pv. vesicatoria Secretes Proteases and Xylanases via the Xps Type II Secretion System and Outer Membrane VesiclesMagali Solé, Felix Scheibner, Anne-Katrin Hoffmeister, et al.
Advances in Therapy|December 14, 2020
Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician SurveyAmy Olson, Nadine Hartmann, Padmaja Patnaik, et al.
Annals of the American Thoracic Society|June 24, 2020
Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO RegistryMargaret L Salisbury, Craig S Conoscenti, Daniel A Culver, et al.
Clinical Breast Cancer|June 12, 2026
Prevalence and Prognostic Implications of Circulating Tumor Cells Among Patients Undergoing Neoadjuvant Chemotherapy for Early-Stage Breast CancerMark Freeman, Alicja Prawdzic Senkowska, Rania Chehade, et al.
American Journal of Respiratory Cell and Molecular Biology|January 23, 2018
Riboflavin Metabolism Variation among Clinical Isolates of Streptococcus pneumoniae Results in Differential Activation of Mucosal-associated Invariant T CellsNadine Hartmann, Curtis McMurtrey, Michelle L Sorensen, et al.
Pageof 3